These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 36513587)

  • 1. Effects of Contralateral Deep Brain Stimulation and Levodopa on Subthalamic Nucleus Oscillatory Activity and Phase-Amplitude Coupling.
    Farokhniaee A; Marceglia S; Priori A; Lowery MM
    Neuromodulation; 2023 Feb; 26(2):310-319. PubMed ID: 36513587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eight cylindrical contact lead recordings in the subthalamic region localize beta oscillations source to the dorsal STN.
    Tamir I; Wang D; Chen W; Ostrem JL; Starr PA; de Hemptinne C
    Neurobiol Dis; 2020 Dec; 146():105090. PubMed ID: 32977021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronised spiking activity underlies phase amplitude coupling in the subthalamic nucleus of Parkinson's disease patients.
    Meidahl AC; Moll CKE; van Wijk BCM; Gulberti A; Tinkhauser G; Westphal M; Engel AK; Hamel W; Brown P; Sharott A
    Neurobiol Dis; 2019 Jul; 127():101-113. PubMed ID: 30753889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Unilateral Subthalamic Nucleus Deep Brain Stimulation on Contralateral Subthalamic Nucleus Local Field Potentials.
    Hasegawa H; Fischer P; Tan H; Pogosyan A; Samuel M; Brown P; Ashkan K
    Neuromodulation; 2020 Jun; 23(4):509-514. PubMed ID: 32281215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthalamic oscillatory activities at beta or higher frequency do not change after high-frequency DBS in Parkinson's disease.
    Foffani G; Ardolino G; Egidi M; Caputo E; Bossi B; Priori A
    Brain Res Bull; 2006 Mar; 69(2):123-30. PubMed ID: 16533660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological effects of dual target DBS in an individual with Parkinson's disease and a sensing-enabled pulse generator.
    Cummins DD; Sandoval-Pistorius SS; Cernera S; Fernandez-Gajardo R; Hammer LH; Starr PA
    Parkinsonism Relat Disord; 2024 May; 122():106089. PubMed ID: 38460490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subthalamic deep brain stimulation at individualized frequencies for Parkinson disease.
    Tsang EW; Hamani C; Moro E; Mazzella F; Saha U; Lozano AM; Hodaie M; Chuang R; Steeves T; Lim SY; Neagu B; Chen R
    Neurology; 2012 Jun; 78(24):1930-8. PubMed ID: 22592373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic local field potential oscillations during ongoing deep brain stimulation in Parkinson's disease.
    Rossi L; Marceglia S; Foffani G; Cogiamanian F; Tamma F; Rampini P; Barbieri S; Bracchi F; Priori A
    Brain Res Bull; 2008 Jul; 76(5):512-21. PubMed ID: 18534260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of inter-electrode distance on subthalamic nucleus local field potential recordings in Parkinson's disease.
    Averna A; Marceglia S; Arlotti M; Locatelli M; Rampini P; Priori A; Bocci T
    Clin Neurophysiol; 2022 Jan; 133():29-38. PubMed ID: 34794045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of levodopa and ongoing deep brain stimulation on subthalamic beta oscillations in Parkinson's disease.
    Giannicola G; Marceglia S; Rossi L; Mrakic-Sposta S; Rampini P; Tamma F; Cogiamanian F; Barbieri S; Priori A
    Exp Neurol; 2010 Nov; 226(1):120-7. PubMed ID: 20713047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of levodopa and deep brain stimulation on subthalamic local field low-frequency oscillations in Parkinson's disease.
    Giannicola G; Rosa M; Marceglia S; Scelzo E; Rossi L; Servello D; Menghetti C; Pacchetti C; Zangaglia R; Locatelli M; Caputo E; Cogiamanian F; Ardolino G; Barbieri S; Priori A
    Neurosignals; 2013; 21(1-2):89-98. PubMed ID: 22538235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and effective connectivity in subthalamic local field potential recordings of patients with Parkinson's disease.
    Hohlefeld FU; Huchzermeyer C; Huebl J; Schneider GH; Nolte G; Brücke C; Schönecker T; Kühn AA; Curio G; Nikulin VV
    Neuroscience; 2013 Oct; 250():320-32. PubMed ID: 23876322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in subthalamic 8-35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease.
    Kühn AA; Kupsch A; Schneider GH; Brown P
    Eur J Neurosci; 2006 Apr; 23(7):1956-60. PubMed ID: 16623853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subthalamic beta oscillations are attenuated after withdrawal of chronic high frequency neurostimulation in Parkinson's disease.
    Trager MH; Koop MM; Velisar A; Blumenfeld Z; Nikolau JS; Quinn EJ; Martin T; Bronte-Stewart H
    Neurobiol Dis; 2016 Dec; 96():22-30. PubMed ID: 27553876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinsonism and vigilance: alteration in neural oscillatory activity and phase-amplitude coupling in the basal ganglia and motor cortex.
    Escobar Sanabria D; Johnson LA; Nebeck SD; Zhang J; Johnson MD; Baker KB; Molnar GF; Vitek JL
    J Neurophysiol; 2017 Nov; 118(5):2654-2669. PubMed ID: 28835526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthalamic local field potentials in Parkinson's disease and isolated dystonia: An evaluation of potential biomarkers.
    Wang DD; de Hemptinne C; Miocinovic S; Qasim SE; Miller AM; Ostrem JL; Galifianakis NB; San Luciano M; Starr PA
    Neurobiol Dis; 2016 May; 89():213-22. PubMed ID: 26884091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-coupled high-frequency activity and beta-locked neuronal spiking in the subthalamic nucleus of Parkinson's disease.
    Yang AI; Vanegas N; Lungu C; Zaghloul KA
    J Neurosci; 2014 Sep; 34(38):12816-27. PubMed ID: 25232117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tremor reduction by subthalamic nucleus stimulation and medication in advanced Parkinson's disease.
    Blahak C; Wöhrle JC; Capelle HH; Bäzner H; Grips E; Weigel R; Hennerici MG; Krauss JK
    J Neurol; 2007 Feb; 254(2):169-78. PubMed ID: 17334951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subthalamic stimulation and levodopa modulate cortical reactivity in Parkinson's patients.
    Casula EP; Stampanoni Bassi M; Pellicciari MC; Ponzo V; Veniero D; Peppe A; Brusa L; Stanzione P; Caltagirone C; Stefani A; Koch G
    Parkinsonism Relat Disord; 2017 Jan; 34():31-37. PubMed ID: 27771287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.